NLRP3 and Cognitive impairment: Taken together, our results demonstrate that the NLRP3 inflammasome participates in the pathogenesis of cognitive deficits in EAE animals, and that pretreatment with an NLRP3 inhibitor could significantly ameliorate EAE-related cognitive deficits and reduce the hippocampal pathology.